The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on September 8, 2026

2 hours ago

Zoth Becomes the First Neobank to Bring Tokenized Stocks Onchain with zVaults, Opening US Equity Markets to the Global South

Indeterminate GlobeNewswire

2 hours ago

Puerto Rico Financial Services Forum Returns as a Premier Caribbean Gathering for Banking and Insurance Leaders

Indeterminate GlobeNewswire

4 hours ago

Carlin Gold Announces $21.5 Million Strategic Investment by Electrum Gold Exploration and $8.5 Million Private Placement with Canaccord Genuity

Indeterminate GlobeNewswire

4 hours ago

NeOnc' Phase 2 Data Could Put Cancer on the Ropes

Indeterminate GlobeNewswire

4 hours ago

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

Indeterminate GlobeNewswire

4 hours ago

Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer

Indeterminate GlobeNewswire

4 hours ago

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

Indeterminate GlobeNewswire

4 hours ago

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

4 hours ago

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

Indeterminate GlobeNewswire

4 hours ago

Greenland Mines Enters New Era as Rare Earths and Critical Minerals Company, Achieves Full Nasdaq Compliance and Sets Biotech Spin-Off for Q4

Indeterminate GlobeNewswire

4 hours ago

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

Indeterminate GlobeNewswire

4 hours ago

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Indeterminate GlobeNewswire

5 hours ago

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

5 hours ago

Maxus Mining Expands Hurley West Antimony Project to Cover Historic Stibnite Prospect with Historical Results up to 16.9% Sb

Indeterminate GlobeNewswire

5 hours ago

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

5 hours ago

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

5 hours ago

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

5 hours ago

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

5 hours ago

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

5 hours ago

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire